It has been demonstrated that miR-145 downregulates ADAM17 protein expression by directly targeting the 3′untranslated region (3′UTR) of ADAM17 mRNA, thereby reducing the proliferation and invasion of renal cancer cells. The gene discussed is ADAM17; the disease is renal carcinoma.